Printer-friendly versionPDF versionSend to friend

David Newby

Profile

on
Title: 
Prof
David
Newby
Admin unit: 
Cardiology
Job title: 
British Heart Foundation Professor of Cardiology
Contact email: 
d.e.newby@ed.ac.uk
Telephone: 
0131 242 6515
Room: 
SU314
Location: 
Chancellors /QMRI
Address: 
49 Little France Crescent

Research

Background: 

Professor David Newby graduated from the University of Southampton with a Bachelor of Science and Bachelor of Medicine degree in 1991. He has worked in Edinburgh for over 20 years and obtained Doctorates in Medicine, Philosophy and Science. Professor Newby is British Heart Foundation John Wheatley Chair of Cardiology at the University of Edinburgh, Director of Research and Development for NHS Lothian, Director of the Wellcome Trust Clinical Research Facility, Director of the Clinical Research Imaging Centre, and a Consultant Interventional Cardiologist at Royal Infirmary of Edinburgh. He is the recipient of a Wellcome Trust Senior Investigator Award.

Research interests: 

Professor Newby has major interests in experimental medicine and the advanced imaging of cardiovascular disease including coronary heart disease, aortic stenosis and heart failure. He has held two British Heart Foundation Programme Grants exploring the atherothrombotic effects of air pollution. He has been involved in several multicentre trials and has played a major role in the conduct of the SALTIRE (Scottish Aortic stenosis Lipid lowering Trial, Impact on REgression) and 3CPO (Health Technology Assessment trial of non-invasive ventilation for acute cardiogenic pulmonary oedema) trials. He was Chief Investigator for the SCOT-HEART trial funded by the Chief Scientist Office; a national multicentre randomised controlled trial of computed tomography coronary angiography in patients attending the Rapid Access Chest Pain Clinic. He is also Chief Investigator of the National Institute for Health Research Efficacy and Mechanism Evaluation-funded MA3RS study: a multicentre trial of magnetic resonance imaging in abdominal aortic aneurysms. 

Responsibilities: 

He has written several successful educational books that have received major national awards (British Medical Association Book Awards, Highly Commended: Coronary Heart Disease: Your Questions Answered; Society of Authors, First Prize (Richard Asher Prize): Cardiology: An Illustrated Coloured Text). Professor Newby is Associate Editor of Heart and Chair for the development of the Scottish Intercollegiate Guideline Network (SIGN) guidelines for the management of acute coronary syndromes.


Grants

Funding body Principal grant holder Title Start date End date Amount
1 British Heart Foundation David Newby BHF Scholarship Scheme : Everett 01/08/2015 31/10/2016 64328
2 Wellcome Trust David Newby Identification and prediction of coronary artery plaque rupture using 18F-fluoride positron emission tomography 01/01/2015 31/07/2019 2334774
3 Astra Zeneca David Newby Investigator Initiated-Sponsored Clniical Research Agreement 08/12/2014 01/11/2017 413487
4 British Heart Foundation Marc Dweck Modification of calcification activity and 18F-Fluoride positron emission tomography uptake in cardiovascular disease. 01/12/2014 01/12/2019 976514
5 National Institute for Health Research David Newby Rapid Assessment of Potential Ischaemic Heart Disease with CTCA. The role of early CT coronary Angiography in the evaluation, intervention and outcome of patients presenting to the Emergency Department with suspected or confirmed Acute Coronary Syndrome. 01/10/2014 30/09/2018 23849
6 British Heart Foundation Marc Dweck 18F-fluoride in the identification of bioprosthetic valve degeneration following surgical and transcatheter implantation. 01/08/2014 31/07/2017 294956
7 Wellcome Trust David Newby Identification and prediction of coronary artery plaque rupture using 18F-fluoride positron emission tomorgraphy 01/08/2014 31/07/2019 2334774
8 Heart Foundation David Newby Overseas research Training Fellowship 01/08/2014 31/07/2015 50000
9 Chief Scientist Office Jennifer Richards 18F-Sodium fluoride imaging of abdominal aortic aneurysms 01/07/2014 30/06/2017 254663
10 Peter Palmer Liferent Trust David Newby Effects of soluble epoxide hydolase inhibition on tissue plasminogen activator release 01/03/2014 28/02/2015 50000